Arab-Israeli Professor Ashraf Brik (see here previously) of Israel’s Technion and his team have overcome a 60-year technical problem to synthesize plectasin, a peptide with promising antibiotic results against multi-resistant bacteria, and linaclotide, to treat irritable bowel syndrome.
https://www.technion.ac.il/en/2021/02/six-decades-old-protein-synthesis-problem-solved-at-technion/